TransMedics Group, Inc.TMDXNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
+175.3%/yr
vs -26.9%/yr prior
Acceleration
+202.2pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
20.9x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 333.80% |
| Q3 2025 | -31.07% |
| Q2 2025 | 35.53% |
| Q1 2025 | 280.00% |
| Q4 2024 | 53.85% |
| Q3 2024 | -64.86% |
| Q2 2024 | 0.00% |
| Q1 2024 | 208.33% |
| Q4 2023 | 115.38% |
| Q3 2023 | -2432.47% |
| Q2 2023 | 62.30% |
| Q1 2023 | 61.10% |
| Q4 2022 | 16.00% |
| Q3 2022 | 39.02% |
| Q2 2022 | -7.89% |
| Q1 2022 | 17.39% |
| Q4 2021 | 2.13% |
| Q3 2021 | -20.51% |
| Q2 2021 | -34.48% |
| Q1 2021 | -26.09% |
| Q4 2020 | -21.05% |
| Q3 2020 | 47.22% |
| Q2 2020 | 14.29% |
| Q1 2020 | 2.33% |
| Q4 2019 | -10.26% |
| Q3 2019 | 44.29% |
| Q2 2019 | -94.44% |
| Q1 2019 | 10.00% |
| Q4 2018 | -14.29% |
| Q3 2018 | 16.67% |
| Q2 2018 | -23.53% |
| Q1 2018 | 66.00% |
| Q4 2017 | 2.91% |
| Q3 2017 | 16.94% |
| Q3 2017 | -1.64% |
| Q2 2017 | 0.00% |